logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
K

Katsuyoshi Matsuoka

toho university sakura medical center

52H指数
436论文数
1.0W被引数
收录论文 151
发表时间
logo
Effectiveness, safety, and clinical outcomes of treatment with the oral α4-integrin antagonist carotegrast methyl in patients with active ulcerative colitis: a multicenter observational study (CANAL study)奥法木单抗（carotegrast methyl）口服α4整合素拮抗剂治疗活动性溃疡性结肠炎的有效性、安全性和临床结局：一项多中心观察性研究（CANAL研究）
errInflammatory Bowel Diseases
IF4.3
err2026-09-28
err0
errOAAI
errFumihito Hirai, MD, PhD; Katsuyoshi Matsuoka, MD, PhD; Kenji Watanabe, MD, PhD; Ryota Hokari, MD, PhD; Taku Kobayashi, MD, PhD; Masayuki Saruta, MD, PhD; Hiroshi Nakase, MD, PhD; Takayuki Yamamoto, MD, PhD; Mao Matsubayashi, MD, PhD; Ryuichi Okamoto, MD, PhD; Shinichiro Shinzaki, MD, PhD; Makoto Naganuma, MD, PhD; Hitoshi Hongo, MD, PhD; Hirozumi Obata, MD, PhD; Katsuya Endo, MD, PhD; Akihiro Yamada, MD, PhD; Shinya Ashizuka, MD, PhD; Noritaka Takatsu, MD, PhD; Toshiyuki Sakurai, MD, PhD; Tetsuya Ishida, MD, PhD; Jun Kato, MD, PhD; Masayuki Fukata, MD, PhD; Yusuke Takashima, MD; Yoshiyuki Hosoi, BSc; Takahiro Suzuki, MSc; Gakuto Yamazaki, BS; Toshifumi Hibi, MD, PhD; Mamoru Watanabe, MD, PhD; Tadakazu Hisamatsu, MD, PhD
err分享
err收藏
Using Pre-Study Patient Interviews to Refine Electronic Patient-Reported Outcomes in Clinical Research of Ustekinumab Induction for Ulcerative Colitis (SIRIUS Study)利用预研究患者访谈优化溃疡性结肠炎ustekinumab诱导治疗临床试验中的电子患者报告结局（SIRIUS研究）
errAdvances in Therapy
IF4
err2026-09-21
err0
errOAAI
errKatsumasa Nagano; Shun Emoto; Yukiko Nishimura; Mizue Sugi; Mizuki Amano; Shinichi Yoshigoe; Kunihiro Nishimura; Katsuyoshi Matsuoka
err分享
err收藏
The trajectory of inflammatory bowel disease in east and southeast Asia: transitioning from acceleration in incidence to compounding prevalence东亚和东南亚炎症性肠病的演变轨迹：从发病率加速增长到患病率叠加增长
errLancet Gastroenterology & Hepatology
IF38.6
err2026-08-12
err0
PREAI
errShinji Okabayashi; Lindsay Hracs; Joseph W Windsor; Julia Gorospe; Stephanie Coward; Raja Affendi Raja Ali; Ida Hilmi; Tadakazu Hisamatsu; Joyce W Y Mak; Ren Mao; Katsuyoshi Matsuoka; Yoshitaka Murakami; Siew C Ng; Sang Hyoung Park; Zhihua Ran; Jeongkuk Seo; Suk-Kyun Yang; Gilaad G Kaplan
err分享
err收藏
Data-driven subphenotyping uncovers ulcerative colitis subtype with high risk for relapse in Japan: a prospective multicenter cohort study数据驱动的亚型分析揭示了日本溃疡性结肠炎中复发风险高的亚型：一项前瞻性多中心队列研究
errLancet Regional Health-Western Pacific
IF8.1
err2026-07-24
err0
errOAAI
errYohei Mikami; Hajime Yamazaki; Tadakazu Hisamatsu; Masakazu Nagahori; Taku Kobayashi; Maria Yonezawa; Shinichiro Shinzaki; Toshimitsu Fujii; Masayuki Saruta; Satoshi Motoya; Takayuki Yamamoto; Minoru Matsuura; Teppei Omori; Shunichi Fukuhara; Katsuyoshi Matsuoka
err分享
err收藏
Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL-23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease亚太胃肠病学协会(APAGE)关于小分子和IL-23 p19抑制剂在溃疡性结肠炎和克罗恩病中应用的临床实践指南
errJournal of Gastroenterology and Hepatology
IF3.4
err2026-05-12
err0
errOAAI
errChoon Jin Ooi; Khoon Lin Ling; Julajak Limsrivilai; Shu-Chen Wei; Joyce Wing Yan Mak; Taku Kobayashi; Luan Minh Dang; Rupert W. Leong; Huiyu Lin; Meng-Tzu Weng; Wan Chee Ong; Vineet Ahuja; Satimai Aniwan; Ryota Hokari; Wei Jie Jonathan Lee; Alex Hwong-Ruey Leow; Wai-Keung Leung; Wee-Chian Lim; Govind Makharia; Katsuyoshi Matsuoka; Nazri Mustaffa; Siew-Chien Ng; Mathew Philip; Pises Pisespongsa; Raja Affendi Raja Ali; Zhi Hua Ran; Marcellus Simadibrata; Jose Sollano; Malcolm Tan; Hang Dao Viet; Nik Razima Wan Ibrahim; Kai Chun Wu; Byong Duk Ye; Ida Hilmi; Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease Committee and Asian Education Network in IBD (AEN-IBD)
err分享
err收藏
Guselkumab efficacy and safety in East Asian participants with moderately to severely active Crohn's disease: subgroup analysis of the phase 3 GALAXI 2 and GALAXI 3 trials古塞库单抗在东亚中度至重度活动性克罗恩病患者中的疗效与安全性：GALAXI 2和GALAXI 3三期试验的亚组分析
errIntestinal Research
IF3.9
err2026-05-01
err0
PREAI
errNakase, Hiroshi; Chen, Baili; Cao, Qian; Matsuoka, Katsuyoshi; Hisamatsu, Tadakazu; Park, Dong Il; Herr, Keira; Wahking, Bryan; Yiu, Wai Chun; Zhuo, Jianmin; Chen, Minhu
err分享
err收藏
Correction: Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study)修正：优化溃疡性结肠炎中卡博格斯特甲酯的使用：患者特征分析、预测性生物标志物及疗效评价时机的优化（ASPECT研究）
errJournal of Gastroenterology
IF5.5
err2026-04-10
err0
errOAAI
errKatsuyoshi Matsuoka; Fumihito Hirai; Kenji Watanabe; Ryota Hokari; Taku Kobayashi; Masayuki Saruta; Hiroshi Nakase; Takahiro Suzuki; Gakuto Yamazaki; Toshifumi Hibi; Mamoru Watanabe; Tadakazu Hisamatsu
err分享
err收藏
Beyond the mucosa: intestinal ultrasound for post-endoscopic healing risk stratification in ulcerative colitis超越黏膜：肠超声在溃疡性结肠炎内镜治疗后愈合风险评估中的应用
errJournal of Crohns & Colitis
IF8.7
err2026-02-01
err0
PREAI
errSagami, Shintaro; Matsuoka, Katsuyoshi; Kobayashi, Taku
err分享
err收藏
Predictive factors for primary nonresponse to biologics in ulcerative colitis: a prospective multicenter study溃疡性结肠炎对生物制剂的原发无应答预测因素：一项前瞻性多中心研究
errJournal of Gastroenterology
IF5.5
err2025-11-07
err0
PREAI
errAtsushi Yoshida; Tomohisa Takagi; Kousaku Kawashima; Kei Moriya; Shigeki Bamba; Shintaro Sagami; Tomoyuki Hayashi; Motoki Kaneko; Takeo Naito; Shuji Kanmura; Kohei Asaeda; Shunji Ishihara; Shinsaku Nagamatsu; Yutaka Endo; Fumiaki Ueno; Toshio Morizane; Katsuyoshi Matsuoka; Toshifumi Hibi
err分享
err收藏
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a post hoc analysis of safety and effectiveness in older (≥ 65 years) and younger (<65 years) patients日本溃疡性结肠炎患者中托法替布上市后监测：一项针对老年（≥65岁）和年轻（<65岁）患者安全性与有效性的事后分析
errINTESTINAL RESEARCH
IF3.9
err2025-11-01
err0
PREAI
errMatsuoka, Katsuyoshi; Yamamoto, Takayuki; Matsuura, Minoru; Fujii, Toshimitsu; Arai, Shoko; Endo, Yutaka; Sato, Keiko; Yuasa, Hirotoshi; Mizuno, Yasushi; Kobayashi, Yuki; Hisamatsu, Tadakazu
err分享
err收藏
Efficacy and Safety of Icotrokinra, a Targeted Oral Peptide That Selectively Blocks IL-23 Receptor Activation, in Ulcerative Colitis: Results From Week 28 of ANTHEM-UC, a Phase 2b Dose-Ranging Trial伊克罗金拉（Icotrokinra）在溃疡性结肠炎中的疗效与安全性：一项2b期剂量范围试验ANTHEM-UC第28周的结果，伊克罗金拉是一种靶向口服肽，可选择性地阻断IL-23受体激活。
errAMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
err2025-10-01
err0
PREAI
errJairath, Vipul; Siegmund, Britta; Surace, Lindsey; Erondu, Ngozi; Chen, Minhu; Chachu, Karen; Louis, Edouard; Matsuoka, Katsuyoshi; Limdi, Jimmy; Arthur, Edmund; Houck, Nicole; Frustaci, Mary Ellen; Zhan, Joyce; Rydzewska, Grazyna; Loftus, Edward V.; Abreu, Maria T.
err分享
err收藏
Post-marketing Surveillance of Tofacitinib in Patients With Ulcerative Colitis in Japan: A Post Hoc Analysis of Safety and Effectiveness by Prior Biologic Status日本溃疡性结肠炎患者托法替尼上市后监测：一项按先前生物制剂使用情况进行的疗效与安全性事后分析
errCROHNS & COLITIS 360
IF0
err2025-10-01
err0
PREAI
errMatsuoka, Katsuyoshi; Motoya, Satoshi; Shinzaki, Shinichiro; Mikami, Yohei; Adachi, Chihiro; Arai, Shoko; Endo, Yutaka; Sato, Keiko; Yuasa, Hirotoshi; Mizuno, Yasushi; Hisamatsu, Tadakazu
err分享
err收藏
A Multicenter Observational Study for the Establishment of Novel Severity Criteria Including Endoscopic Evaluation for Intestinal Behçet's Disease一项多中心观察性研究，旨在建立包含内镜评估的新型肠道白塞病严重程度标准
errDigestive Endoscopy
IF4.7
err2025-09-27
err0
errOAAI
errToshiro Fukui; Makoto Naganuma; Yohei Kirino; Reiko Kunisaki; Yohei Mikami; Nobuhiro Ueno; Junji Umeno; Shigeki Bamba; Makoto Ooi; Shuhei Hosomi; Takayuki Matsumoto; Katsuyoshi Matsuoka; Chikako Watanabe; Masakazu Nagahori; Motoi Uchino; Kenji Watanabe; Fumihito Hirai; Minoru Matsuura; Yoshiya Tanaka; Mitsuhiro Takeno; Tadakazu Hisamatsu
err分享
err收藏
Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study)优化卡托格斯特甲基在溃疡性结肠炎中的使用：患者特征分析、预测性生物标志物及疗效评估时机（ASPECT研究）
errJournal of Gastroenterology
IF5.5
err2025-09-22
err0
errOAAI
errKatsuyoshi Matsuoka; Fumihito Hirai; Kenji Watanabe; Ryota Hokari; Taku Kobayashi; Masayuki Saruta; Hiroshi Nakase; Takahiro Suzuki; Gakuto Yamazaki; Toshifumi Hibi; Mamoru Watanabe; Tadakazu Hisamatsu
err分享
err收藏
Nationwide estimates of patient numbers and prevalence rates of ulcerative colitis and Crohn’s disease in Japan in 20232023年日本全国溃疡性结肠炎和克罗恩病患者数量及患病率的估计值
errJournal of Gastroenterology
IF5.5
err2025-09-02
err0
PREAI
errAnna Tsutsui; Yoshitaka Murakami; Yuji Nishiwaki; Keiko Asakura; Satoko Ohfuji; Wakaba Fukushima; Katsuyoshi Matsuoka; Tadakazu Hisamatsu
err分享
err收藏
Asia Pacific association of gastroenterology consensus statements on histopathological evaluation of inflammatory bowel diseases亚太胃肠病学协会关于炎症性肠病组织病理学评估的共识声明
errTherapeutic Advances in Gastroenterology
IF3.4
err2025-08-19
err0
errOAAI
errRupert W. Leong; Thanaboon Chaemsupaphan; Huiyu Lin; Wee Chian Lim; Choon Jin Ooi; John D. Chetwood; Ren Mao; Hsin Yun Wu; Shu Chen Wei; Govind Makharia; Vineet Ahuja; Rupa Banerjee; Raja Atreya; Julajak Limsrivilai; Satimai Aniwan; Pises Pisespongsa; Ida Hilmi; Raja Affendi Raja Ali; Wai Keung Leung; Siew C. Ng; Byong Duk Ye; Taku Kobayashi; Katsuyoshi Matsuoka; Cora Chau; Anapat Sanpavat; Chia-Tung Shun; Pavitratha Puspanathan; Richard B. Gearry; Silvio Danese; Christopher Ma; Aviv Pudipeddi; Sudarshan Paramsothy
err分享
err收藏
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data日本溃疡性结肠炎患者中托法替尼上市后监测：安全性及有效性数据的最终报告
errJOURNAL OF GASTROENTEROLOGY
IF5.5
err2025-04-21
err0
errOAAI
errMatsuoka, Katsuyoshi; Motoya, Satoshi; Yamamoto, Takayuki; Matsuura, Minoru; Fujii, Toshimitsu; Mikami, Yohei; Oshima, Junichi; Endo, Yutaka; Yuasa, Hirotoshi; Hoshi, Masato; Sato, Keiko; Hisamatsu, Tadakazu
err分享
err收藏
BASELINE PROGNOSTIC FACTORS OF BOWEL URGENCY IMPROVEMENT IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH MIRIKIZUMAB溃疡性结肠炎患者经Mirikizumab治疗后肠道急迫性改善的基线预后因素
errINFLAMMATORY BOWEL DISEASES
IF4.3
err2025-02-28
err0
PREAI
errDubinsky, Marla; Schreiber, Stefan; Matsuoka, Katsuyoshi; Al-Bawardy, Badr; Pellanda, Paola; Zhu, Baojin; Bleakman, Alison Potts; Redondo, Isabel; Owen, Charles; Limdi, Jimmy
err分享
err收藏
Guselkumab efficacy and safety in East Asian participants with moderate to severely active Crohn's disease: Subgroup analysis of the GALAXI 2 & 3 Phase 3 studies
errJOURNAL OF CROHNS & COLITIS
IF8.7
err2025-01-22
err0
PREAI
errNakase, H.; Chen, B.; Cao, Q.; Matsuoka, K.; Hisamatsu, T.; Park, D., I; Wahking, B.; Yiu, W. C.; Zhuo, J.; Chen, M.
err分享
err收藏
Impact of filgotinib on health-related quality of life over 3 years in Japanese patients with Ulcerative Colitis: A post hoc analysis of the SELECTION and SELECTION long-term extension trials
errJOURNAL OF CROHNS & COLITIS
IF8.7
err2025-01-22
err0
PREAI
errMatsuoka, K.; Schreiber, S.; Hata, E.; Kaise, T.; Hibi, T.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
S
Stefan Schreiber
H 指数: 192 · 论文数: 1.9K
S
Silvio Danese
H 指数: 139 · 论文数: 2.3K
L
Laurent Peyrin‐Biroulet
H 指数: 137 · 论文数: 2.1K
B
Brian G. Feagan
H 指数: 136 · 论文数: 1.3K
M
Michael T. Lotze
H 指数: 134 · 论文数: 897
查看更多